Northwestern University Feinberg School of Medicine

News Center

Posts

  • Combination Therapy Improves Outcomes for Rare Blood Disorder

    A combination treatment has shown promise for treating a rare blood disease, according to a clinical trial published in the journal Blood.

  • Uncovering the Molecular Drivers of B-cell Lymphoma Tumor Growth

    Northwestern Medicine scientists have uncovered a key pathway controlling tumor growth in B-cell lymphomas, according to a study published in the Journal of Clinical Investigation.

  • Northwestern researchers have found that a new microbial therapy could offer hope to millions affected by the autoimmune disease vitiligo, which causes visible patches of skin discoloration and carries profound emotional and physical consequences. (Getty Images)

    Microbial Therapy Offers New Hope for Vitiligo Patients

    A natural compound derived from gut-friendly bacteria can significantly slow the progression of vitiligo and may restore pigmentation, according to a new study.